GSTT1 Gene - Glutathione S-Transferase Theta 1

Genetic Variant, Detoxification, and Disease Susceptibility

Gene Information Card

Symbol GSTT1
Full Name Glutathione S-Transferase Theta 1
Gene Type protein-coding
Chromosomal Location 22q11.23
NCBI Gene ID 2952 ncbi.nlm.nih.gov/gene/2952
Ensembl ID ENSG00000168765
UniProt ID P30711
OMIM ID 600436
HGNC ID 4641
Aliases GSTT1-1, GSTT1*0, GSTT1*A, GSTT1*B

Description

The GSTT1 gene encodes a member of the glutathione S-transferase (GST) superfamily, specifically the theta class. These enzymes catalyze the conjugation of reduced glutathione to a wide variety of electrophilic compounds, including carcinogens, therapeutic drugs, and environmental toxins. GSTT1 is highly polymorphic; a common homozygous deletion (null genotype) results in complete loss of enzyme activity and is associated with altered susceptibility to various cancers and adverse drug reactions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Bladder Cancer Null genotype reduces detoxification of carcinogens, increasing risk Meta-analysis in multiple populations; ClinVar association
Asthma GSTT1 null genotype linked to increased oxidative stress and airway inflammation Case-control studies; OMIM #600436
Chemotherapy Toxicity Null genotype impairs clearance of chemotherapeutic agents (e.g., busulfan, cyclophosphamide) Pharmacogenetic studies; ClinVar
Colorectal Cancer Loss of GSTT1 activity may increase DNA damage from dietary carcinogens Epidemiological studies; COSMIC
Acute Myeloid Leukemia GSTT1 deletion associated with higher risk, especially in combination with GSTM1 null Case-control studies; NCBI GeneRIF

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 8.3 Medium
Lung 6.1 Low
Small Intestine 15.2 Medium
Colon 9.7 Medium
Breast 4.5 Low
Prostate 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.1 Hepatocellular carcinoma cell line
A549 7.2 Lung adenocarcinoma cell line
MCF7 5.0 Breast cancer cell line
HT-29 10.3 Colorectal adenocarcinoma cell line
K562 2.1 Chronic myeloid leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
GSTT1*0 (deletion) Copy number loss (homozygous null) ~20-50% of populations (varies by ethnicity) Complete loss of enzyme activity
GSTT1*A (rs17856199) Missense (Ile105Val) <1% Reduced catalytic activity
GSTT1*B (rs2234953) Missense (Ala114Val) <1% Altered substrate specificity
Mutation functional classification

Loss of Function (LOF)

Homozygous deletion (GSTT1*0) results in complete absence of protein and enzyme activity, impairing detoxification of electrophilic compounds.

Gain of Function (GOF)

No known gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations described.

Pathways

Glutathione metabolism (KEGG: hsa00480)
Metabolism of xenobiotics by cytochrome P450 (KEGG: hsa00980)
Drug metabolism - cytochrome P450 (KEGG: hsa00982)
Chemical carcinogenesis (KEGG: hsa05204)

Protein Summary

GSTT1 is a 240-amino acid cytosolic enzyme (27.3 kDa) that forms homodimers. It catalyzes the conjugation of glutathione to a broad range of electrophilic substrates, including halogenated hydrocarbons, epoxides, and arene oxides. The enzyme is expressed primarily in liver, kidney, and gastrointestinal tract, playing a critical role in detoxification of environmental carcinogens and drugs. The common null allele (GSTT1*0) leads to complete loss of activity and is a well-studied genetic risk factor for various cancers and drug toxicities.

Related Products

Product name Cat.No. Species Gene ID
GSTT1 Knockout HEK293 Cell Line EDJ-KQ4815 Human 2952 Details Get a Quote
GSTT1 Knockout A-549 Cell Line EDJ-KQ27589 Human 2952 Details Get a Quote
GSTT1 Knockout HCT 116 Cell Line EDJ-KQ27590 Human 2952 Details Get a Quote
GSTT1 Knockout HeLa Cell Line EDJ-KQ27591 Human 2952 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: